<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="paperszoo1\PMC4260661\results\search\disease\results.xml">
  <result pre="and systemic immune responses using intranasal delivery of whole, inactivated" exact="influenza" post="vaccine powder formulations. Powder-formulated vaccine elicited a significant serum"/>
  <result pre="vaccine efficacy mediated by nanoparticle delivery by intranasal delivery, against" exact="influenza" post="virus, parainfluenza, hepatitis B, and Streptococcus pneumoniae pathogens. Knowledge"/>
  <result pre="by nanoparticle delivery by intranasal delivery, against influenza virus, parainfluenza," exact="hepatitis" post="B, and Streptococcus pneumoniae pathogens. Knowledge about the protective"/>
  <result pre="and mucosal immune responses by nasal vaccination with whole inactivated" exact="influenza" post="virus has been reported in rats.34,57 Our results indicated"/>
  <result pre="antigensAtassiMZBachrachHLImmunobiology of Proteins and Peptides-IIINew York, NYPlenum Press19852746 2RodriguezLLGrubmanMJFoot and" exact="mouth disease" post="virus vaccinesVaccine200927Suppl 4D90D9419837296 3CoxSJParidaSVoyceCet al.Further evaluation of higher potency"/>
  <result pre="vaccinesVaccine19991713â€&quot;141767177110194837 9ZanvitPHavlÃ­ckovÃ¡MTÃ¡cnerJet al.Protective and cross-protective mucosal immunization of mice by" exact="influenza" post="virus type A with bacterial adjuvantImmunol Lett2008115214415218160106 10NeutraMRM cells"/>
  <result pre="and mucosal immune responses to surface-modified PLGA microspheres containing recombinant" exact="hepatitis" post="B antigen administered intranasallyVaccine200624194201421116446012 21ClarkMAJepsonMAHirstBHExploiting M cells for drug"/>
  <result pre="FMDV challengePLoS One2011611e2760522110686 33GarmiseRJStaatsHFHickeyAJNovel dry powder preparations of whole inactivated" exact="influenza" post="virus for nasal vaccinationAAPS Pharm Sci Tech200784E81 34HuangJGarmiseRJCrowderTMet al.A"/>
  <result pre="nasal vaccinationAAPS Pharm Sci Tech200784E81 34HuangJGarmiseRJCrowderTMet al.A novel dry powder" exact="influenza" post="vaccine and intranasal delivery technology: induction of systemic and"/>
  <result pre="of cattleJ Biol Stand19841211111206699023 37GarmiseRJMarKCrowderTMet al.Formulation of a dry powder" exact="influenza" post="vaccine for nasal deliveryAAPS Pharm Sci Tech200671E19 38HamblinCBarnettITHedgerRSA new"/>
  <result pre="responses of pigs following immunisation with high potency foot and" exact="mouth disease" post="vaccineVaccine20022025â€&quot;263197320812163272 52LewisSAMorganDOGrubmanMJExpression, processing, and assembly of foot-and-mouth disease virus"/>
  <result pre="serological study of the full and empty particles of foot-and" exact="mouth disease" post="virusJ Gen Virol1975263227238235596 54ChinsangaramJBeardCMasonPWZellnerMKWardGGrubmanMJAntibody response in mice inoculated with"/>
  <result pre="proteins expressed in heterologous systemsVaccine19931188258298395128 57MoonHJLeeJSTalactacMRet al.Mucosal immunization with recombinant" exact="influenza" post="hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against"/>
  <result pre="protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic" exact="influenza" post="A virusVet Microbiol20121603â€&quot;427728922763171 Figure 1 Construction of the recombinant"/>
 </snippets>
</snippetsTree>
